INTRODUCTION: The estrogen-related receptor alpha (ERRalpha) is an orphan member of the nuclear receptor superfamily that is closely related to estrogen receptor alpha (ERalpha). ERRalpha binds an estrogen response element (ERE), directly competes with ERalpha for binding ERE, and represses ERE-dependent transcription in MCF-7 cells, ER-positive breast cancer cells. OBJECTIVE: We investigated whether ERRalpha modulate some ER-dependent activities in endometrial cancer. METHOD: We investigated protein and mRNA expression of ERRalpha in endometrial cancer using immunohistochemistry and RT-PCR, respectively. After transient transfection using the ERRalpha expression vector (pCI-ERRalpha) or ERRalphaSi, which suppressed the expression of endogenous ERRalpha, Ishikawa cells were assayed for ERE-dependent luciferase activity. Cells stably overexpressing ERRalpha were generated and compared with estrogen-dependent and -independent cell growth. RESULT: ERRalpha was detected in human endometrial cancer tissues by immunohistochemistry. An RT-PCR study showed that mRNA of ERRalpha was expressed in four endometrial cancer cell lines (Ishikawa, Hec1a, KLE, and SNGII) and 11 human endometrial tissues. Overexpression of ERRalpha repressed estrogen-induced ERE-dependent transcriptional activity in Ishikawa cells. After transfection with ERRalphaSi1, the expression of endogenous ERRalpha decreased to 0.5-fold, and estrogen-induced ERE luciferase activity increased to 1.5-fold. The cells stably overexpressing ERRalpha grew up more slowly than control cells in the presence of 10 nm estradiol. CONCLUSION: ERRalpha is expressed in human endometrial cancer tissues and cell lines and suppresses ERE-dependent transcriptional activity in the presence of estrogen. ERRalpha modulates estrogen-induced activity in estrogen-dependent endometrial cancer.
INTRODUCTION: The estrogen-related receptor alpha (ERRalpha) is an orphan member of the nuclear receptor superfamily that is closely related to estrogen receptor alpha (ERalpha). ERRalpha binds an estrogen response element (ERE), directly competes with ERalpha for binding ERE, and represses ERE-dependent transcription in MCF-7 cells, ER-positive breast cancer cells. OBJECTIVE: We investigated whether ERRalpha modulate some ER-dependent activities in endometrial cancer. METHOD: We investigated protein and mRNA expression of ERRalpha in endometrial cancer using immunohistochemistry and RT-PCR, respectively. After transient transfection using the ERRalpha expression vector (pCI-ERRalpha) or ERRalphaSi, which suppressed the expression of endogenous ERRalpha, Ishikawa cells were assayed for ERE-dependent luciferase activity. Cells stably overexpressing ERRalpha were generated and compared with estrogen-dependent and -independent cell growth. RESULT: ERRalpha was detected in humanendometrial cancer tissues by immunohistochemistry. An RT-PCR study showed that mRNA of ERRalpha was expressed in four endometrial cancer cell lines (Ishikawa, Hec1a, KLE, and SNGII) and 11 human endometrial tissues. Overexpression of ERRalpha repressed estrogen-induced ERE-dependent transcriptional activity in Ishikawa cells. After transfection with ERRalphaSi1, the expression of endogenous ERRalpha decreased to 0.5-fold, and estrogen-induced ERE luciferase activity increased to 1.5-fold. The cells stably overexpressing ERRalpha grew up more slowly than control cells in the presence of 10 nm estradiol. CONCLUSION:ERRalpha is expressed in humanendometrial cancer tissues and cell lines and suppresses ERE-dependent transcriptional activity in the presence of estrogen. ERRalpha modulates estrogen-induced activity in estrogen-dependent endometrial cancer.
Authors: Amanda M Esch; Nancy E Thompson; Jennifer A Lamberski; Janet E Mertz; Richard R Burgess Journal: Protein Expr Purif Date: 2012-05-04 Impact factor: 1.650
Authors: Zhaochen Ning; Xiaoling Du; Ju Zhang; Kuo Yang; Lin Miao; Yan Zhu; Hui Yuan; Linlin Wang; Helmut Klocker; Jiandang Shi Journal: Endocrine Date: 2014-04-24 Impact factor: 3.633
Authors: Paula M Heron; Jadwiga Turchan-Cholewo; Annadora J Bruce-Keller; Melinda E Wilson Journal: AIDS Res Hum Retroviruses Date: 2009-11 Impact factor: 2.205
Authors: Vincent Bombail; Douglas A Gibson; Frances Collins; Sheila MacPherson; Hilary O D Critchley; Philippa T K Saunders Journal: J Clin Endocrinol Metab Date: 2010-07-28 Impact factor: 5.958